Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-331037
Filing Date
2013-08-12
Accepted
2013-08-12 16:39:50
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d551852d10q.htm 10-Q 730641
2 EX-31.1 d551852dex311.htm EX-31.1 8884
3 EX-31.2 d551852dex312.htm EX-31.2 8937
4 EX-32.1 d551852dex321.htm EX-32.1 3385
5 EX-32.2 d551852dex322.htm EX-32.2 3391
  Complete submission text file 0001193125-13-331037.txt   6732881

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20130630.xml EX-101.INS 503451
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20130630.xsd EX-101.SCH 34794
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20130630_cal.xml EX-101.CAL 42281
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20130630_def.xml EX-101.DEF 116253
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20130630_lab.xml EX-101.LAB 339086
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20130630_pre.xml EX-101.PRE 235422
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 131030184
SIC: 2834 Pharmaceutical Preparations